U.S. market Open. Closes in 5 hours 4 minutes

NVS | Novartis AG Stock Overview

(Stock Exchange: NYSE)
Day's Range 110.32 - 111.67
52 Week Range 92.35 - 120.92
Beta 0.57
Implied Volatility 25.57%
IV Rank 77.04%
Day's Volume 2,754,933
Average Volume 2,220,672
Shares Outstanding 1,975,090,048
Market Cap 220,183,038,551
Sector Healthcare
Industry Drug Manufacturers - General
IPO Date 1996-11-07
Valuation
Profitability
Growth
Health
P/E Ratio 19.02
Forward P/E Ratio 14.56
EPS 5.86
1YR Price Target 117.00
Dividend Yield 3.44%
Dividend Per Share 3.83
Dividend ExDate 2023-03-09
Dividend PayDate 2023-03-20
Employees 76,057
Country Switzerland
Website NVS
Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The firm sells its products globally, with the United States representing close to one third of total revenue.
NVS's peers: AMRN, AZN, BIIB, GRFS, GSK, RHHBY, BMY, SNY, MRK, BAYRY, GILD, JNJ, ABBV, LLY, PFE, OGN, SCLX
*Chart delayed
Analyzing fundamentals for NVS we got that it has strong fundamentals where Valuation is considered to be significantly undervalued, Profitability is very wealthy, Growth is good and Health is strong. For more detailed analysis please see NVS Fundamentals page.

Watching at NVS technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on NVS Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙